Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
OccuLogix
Age
50–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Study eye must have a diagnosis of non-exudative, "Dry", AMD with equivalent drusen surface area of approximately 31,000 µm2 \[e.g. at least 10 soft, semi-soft intermediate size ≥63µm or at least 3 drusen size ≥125 µm within 3,000 µm of the fovea documented on macular exam, retinal angiography and fundus photographs as determined by the reading center. ETDRS BCVA of 20/40 - 20/100 inclusive
You may not be if
Either eye with previous or active sub-retinal neovascularization (SRNV) or choroidal neovascularization (CNV)
Pigment epithelial detachment (PED) within 500 µm of the fovea
Either eye with a diagnosis of exudative (wet) AMD
Subjects having undergone cataract surgery less than 3 months prior to enrollment without an open posterior capsule
Uncontrolled hypertension and/or diabetes
Subjects with prolonged PT/PTT (unless the subject is taking warfarin), hematocrit \<35%, evidence of active bleeding, platelet count \<100,000/ml
Clareo Health | Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis
